Private equity firm to buy Auslab owner Citadel Group for $503m

The directors of ASX-listed Citadel Group are supporting a bid from private equity firm Pacific Equity Partners (PEP) to buy out the company for $503.1 million.

Citadel Group's healthcare division Citadel Health markets the Evolution laboratory information system, previously known as Auslab, along with the Charm oncology solution.

Citadel recently received an extension to its decades-long contract with Queensland Health for Auslab following the cancellation of the $64 million laboratory information system replacement project with Sunquest. It is also used by NSW Health Pathology and several large health services in Victoria.

Posted in Australian eHealth

Tags: Citadel Health

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2021 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit